Clinical Trials Logo

Bunionectomy clinical trials

View clinical trials related to Bunionectomy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05157841 Completed - Hallux Valgus Clinical Trials

Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy

Start date: February 10, 2022
Phase: Phase 3
Study type: Interventional

The study is conducted sequentially in two parts. Part A: The purpose is to obtain information on PK profile, pharmacodynamics (PD), efficacy, safety, and to assess the performance of 266 mg EXPAREL vs 133 mg EXPAREL. Part B: The purpose is to evaluate the efficacy and safety of the preferred dosage of EXPAREL from Part A compared with bupivacaine HCl.

NCT ID: NCT05087914 Withdrawn - Acute Pain Clinical Trials

Novel Non-opioid Post-surgical Pain Treatment in Females

Start date: November 1, 2021
Phase: Phase 2
Study type: Interventional

This study aims to determine if treatment with Carbidopa/Levodopa and Naproxen in females (biological sex) with acute pain after a bunionectomy or toe fusion (24hrs, 48hrs and 5 days) will reduce pain when compared with females receiving Placebo and Naproxen.

NCT ID: NCT04855240 Completed - Clinical trials for Acute Postoperative Pain

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Start date: March 29, 2021
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain

NCT ID: NCT03782298 Completed - Bunionectomy Clinical Trials

Safety and Performance of PEEK Anchors (Dynomite, Spyromite, Raptomite) in Extremities

Start date: March 12, 2019
Phase:
Study type: Observational

Safety and performance of the study devices in extremities over a time period of 6 months after intervention.

NCT ID: NCT00609466 Completed - Pain Clinical Trials

A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy

Start date: September 2007
Phase: Phase 3
Study type: Interventional

The main objective of this trial is to demonstrate the efficacy and safety of multiple-dose application of oral application of CG5503 IR 75mg compared to placebo and to assess safety and tolerability of CG5503 IR 75mg in subjects following bunionectomy. This trial was performed based on a previously performed double-blind, placebo-controlled, multiple-dose trial in the same indication investigating 3 dose strengths CG5503 IR (50, 75 and 100 mg) published under PMID: 18851776.

NCT ID: NCT00293631 Completed - Orthopedic Surgery Clinical Trials

Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy

Start date: November 2005
Phase: Phase 2
Study type: Interventional

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for management of post-operative pain in patients who have surgical removal of a bunion on the lower extremity. One-fourth of patients in this study will receive a single dose of intravenous ketorolac for management of pain and one-fourth of patients in this study will receive a single dose of an intravenous placebo.

NCT ID: NCT00209560 Terminated - Arthroscopy Clinical Trials

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the safety, tolerability, and efficacy of AQUAVAN® Injection when used for mild-to-moderate sedation in patients undergoing minor surgical procedures.